Project Number 1R43AG072985-01A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Tau mislocalization assay to screen AD therapeutics using compartmentalized chips Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development a. Enabling Technologies Researcher and Organization Principal Investigator TAYLOR, ANNE MARION Principal Investigator First Name ANNE MARION Principal Investigator Last Name TAYLOR Awardee Organization XONA MICROFLUIDICS, LLC Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $268,419 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
